HELLP Syndrome

Key Points

• HELLP is a severe preeclampsia-spectrum complication defined by hemolysis, elevated liver enzymes, and low platelets.
• It can present without overt hypertension or proteinuria, so delayed recognition risk is high.
• Core diagnostic lab pattern includes LDH 600 IU/L or higher, AST/ALT over 2 times upper normal range, and platelets below 100,000/microL.
• HELLP may progress rapidly to hepatic bleeding/rupture, acute kidney injury, and DIC.
• About one-third of cases are diagnosed postpartum; laboratory worsening is common in the first 48 hours after birth.
• Definitive maternal-risk reduction is delivery, with timing based on maternal status and fetal maturity.

Pathophysiology

HELLP syndrome is associated with microvascular endothelial injury, intravascular coagulation activation, and platelet consumption. Hemolysis and hepatic microcirculatory injury drive elevated liver enzymes, thrombocytopenia, and bleeding risk.

Clinical deterioration can be abrupt and include multisystem involvement (hepatic, renal, hematologic, neurologic). Because presentation may mimic viral or gastrointestinal illness, structured cue recognition is essential.

Classification

• Antepartum HELLP: Usually in late pregnancy and often associated with preeclampsia.
• Postpartum HELLP: May first appear after delivery; frequent early postpartum laboratory worsening requires close serial monitoring.
• Complicated HELLP: Hepatic bleeding/rupture, DIC, severe anemia, kidney injury, or hemodynamic instability.

Nursing Assessment

NCLEX Focus

In suspected HELLP, trend-based reassessment and rapid escalation are critical because deterioration can be fast and non-linear.

• Assess severe upper-abdominal pain patterns (epigastric/RUQ/substernal), nausea/vomiting, and unexplained malaise.
• Assess for bleeding-risk and instability cues: hypotension, tachycardia, dyspnea, abdominal distension, and referred pain to shoulder/chest/back/neck (possible hepatic bleeding/rupture).
• Monitor BP, urine output, mental status, perfusion, and respiratory status continuously in severe presentations.
• Trend HELLP-defining labs and coagulation profile:
• LDH 600 IU/L or higher.
• AST/ALT over 2 times upper normal limit.
• Platelets below 100,000/microL.
• In postpartum pathways, repeat labs at least about every 12 hours and anticipate transient worsening in first 48 hours.
• Screen for overlap complications including DIC and kidney injury.

Nursing Interventions

• Activate urgent high-risk obstetric pathway with maternal-fetal and critical-care coordination.
• Begin seizure prophylaxis (typically magnesium-sulfate) and blood-pressure control when hypertensive features are present.
• Use cautious fluid strategy to limit pulmonary-edema risk while maintaining organ perfusion.
• Prepare blood products and coagulation support when anemia, thrombocytopenia, or bleeding complications emerge.
• Coordinate delivery planning:
• In severe or unstable cases, expedite delivery after immediate stabilization.
• In selected pregnancies under 34 weeks without severe deterioration, short delay (up to about 48 hours) may be used for antenatal corticosteroid benefit.
• Continue intensive postpartum surveillance because HELLP may present or worsen after birth.

Hepatic Rupture Emergency

Severe abdominal pain with hemodynamic change in HELLP should be treated as potential hepatic hemorrhage until ruled out.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
magnesium-sulfate	Seizure-prophylaxis infusion	Continue intrapartum/postpartum with reflex, respiratory, urine-output, and toxicity surveillance.
antihypertensives	Nifedipine, labetalol, hydralazine contexts	Used when severe hypertension is present to reduce maternal cerebrovascular risk.
corticosteroids	Antenatal corticosteroid context	In select pregnancies under 34 weeks, short delay for fetal lung maturity may be considered if maternal status allows.

Clinical Judgment Application

Clinical Scenario

A 33-week patient with severe epigastric pain, nausea, malaise, and platelets of 82,000/microL has rapidly rising liver enzymes and hypotension.

• Recognize Cues: Severe abdominal symptoms with HELLP-defining laboratory and perfusion deterioration.
• Analyze Cues: Pattern is concerning for complicated HELLP with hepatic bleeding risk.
• Prioritize Hypotheses: Immediate priorities are maternal stabilization, hemorrhage/DIC risk control, and delivery planning.
• Generate Solutions: Escalate multidisciplinary response, initiate magnesium/blood-pressure strategy, prepare blood products, and coordinate urgent delivery pathway.
• Take Action: Implement high-acuity protocol and continuous reassessment.
• Evaluate Outcomes: Maternal status stabilizes and delivery proceeds with reduced catastrophic-complication risk.

Related Concepts

• preeclampsia - HELLP is a severe preeclampsia-spectrum complication requiring urgent escalation.
• disseminated-intravascular-coagulation-in-pregnancy - HELLP may trigger consumptive coagulopathy and major hemorrhage.
• postpartum-hemorrhage - Thrombocytopenia and hepatic injury increase severe bleeding risk.
• magnesium-sulfate - Core medication for seizure prevention in severe hypertensive-spectrum disease.
• antihypertensives - Severe BP control reduces maternal end-organ injury risk.

Self-Check

1. Which symptom and lab combination should trigger immediate HELLP escalation?
2. Why can HELLP be missed if clinicians rely only on hypertension/proteinuria?
3. What postpartum monitoring strategy is essential in the first 48 hours?